Skip to main content
. 2016 Oct 28;7:371. doi: 10.3389/fphar.2016.00371

Figure 2.

Figure 2

Country distribution of mean time in therapeutic range in the RE-LY trial. Reprinted from Wallentin et al. (2010), Copyright (2010), with permission from Elsevier.